Aberrant RASSF1A methylation levels in malignant tissues and cell-free circulating DNA samples were found to be a better diagnostic and prognostic biomarker in different types of malignancies, including hepatocellular [24] nasopharyngeal [25], and endometrial cancers [26]. The gene discussed is RASSF1; the disease is endometrial cancer.